S. Buhl

发表

Fatigue is a systemic extraintestinal disease manifestation largely independent of disease activity, chronicity, and nutritional deficiencies in inflammatory bowel disease on biologics

T. S. Jørgensen, C. Steenholdt, J. Brynskov, 2022, Scandinavian journal of gastroenterology.

Systematic Information to Health-Care Professionals about Vaccination Guidelines Improves Adherence in Patients With Inflammatory Bowel Disease in Anti-TNFα Therapy

C. Steenholdt, J. Brynskov, O. Thomsen, 2015, The American Journal of Gastroenterology.

Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial

K. Bendtzen, C. Steenholdt, J. Brynskov, 2014, BMJ Open.

Outcome of continued infliximab therapy in Crohn’s disease patients with response but without remission after one year of infliximab – a retrospective cohort study

C. Steenholdt, J. Brynskov, S. Buhl, 2018, Scandinavian journal of gastroenterology.

Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease

O. Nielsen, K. Bendtzen, M. Coskun, 2016, Medicine.

Identifying and understanding disease burden in patients with inflammatory bowel disease

T. S. Jørgensen, C. Steenholdt, J. Brynskov, 2022, BMJ open gastroenterology.

Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease

C. Steenholdt, J. Brynskov, O. Thomsen, 2017, Inflammatory bowel diseases.

Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease

K. Bendtzen, N. Bolstad, C. Steenholdt, 2020, Scandinavian journal of gastroenterology.

High-density SNP arrays improve detection of HER2 amplification and polyploidy in breast tumors

F. Nielsen, T. V. Hansen, S. Buhl, 2015, BMC Cancer.

A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients’ and physicians’ preferences and adherence

C. Steenholdt, J. Brynskov, M. Ainsworth, 2021, Scandinavian journal of gastroenterology.

Drug Levels Associated With Optimal Discrimination Between Remission and Nonremission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease

N. Bolstad, C. Steenholdt, J. Brynskov, 2021, Therapeutic drug monitoring.

Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease

J. Jahnsen, J. Dahlerup, T. Klausen, 2022, NEJM Evidence.